The Current Ratio as of November 2025 (TTM) for ImmuPharma plc (IMMPF) is 1.21

According to ImmuPharma plc’s latest financial reports and current stock price. The company's current Current Ratio is 1.21. This represents a change of 34.92% compared to the average of 0.89 of the last 4 quarters.

ImmuPharma plc (IMMPF) Historical Current Ratio (quarterly & annually)

How has IMMPF Current Ratio performed in the past?

The mean historical Current Ratio of ImmuPharma plc over the last ten years is 3.58. The current 1.21 Current Ratio has changed 3.27% with respect to the historical average. Over the past ten years (40 quarters), IMMPF's Current Ratio was at its highest in in the March 2018 quarter at 11.64. The Current Ratio was at its lowest in in the September 2024 quarter at 0.58.

ImmuPharma plc (IMMPF) Current Ratio by Quarter and Year

Discovering the peaks and valleys of ImmuPharma plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

ImmuPharma plc (IMMPF) Average Current Ratio

How has IMMPF Current Ratio performed in the past?

The current Current Ratio of ImmuPharma plc (IMMPF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

ImmuPharma plc (IMMPF) Current Ratio vs. Peers

How is IMMPF’s Current Ratio compared to its peers?

ImmuPharma plc’s Current Ratio is greater than IntelGenx Technologies Corp. (0.41), greater than LakeShore Biopharma Co., Ltd (1.02), less than IBEX Technologies Inc. (5.69), greater than OKYO Pharma Limited (0.40), greater than Kadimastem Ltd (0.02), less than Alpha Cognition Inc. (1.50), less than Small Pharma Inc. (5.77), greater than Organicell Regenerative Medicine, Inc. (0.27), greater than Generation Hemp, Inc. (0.16), greater than Chill Brands Group PLC (0.80),

Build a custom stock screener for ImmuPharma plc (IMMPF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like ImmuPharma plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

ImmuPharma plc (IMMPF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like ImmuPharma plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.